What’s wrong with ‘over-testing’ for prostate cancer?
According to a recent study at Oxford, celebrity prostate cancer awareness campaigns have contributed to the over-testing of white, wealthy men from the south of Britain for PSA – prostate-specific antigen, a marker used in the diagnosis of the disease. This over-testing, the Oxford academics say, has led to unnecessary treatment, harm to individuals and expense for the NHS. My late husband, Jeremy Clarke, would still be here if he’d been offered a test at 50. He was diagnosed at 56 after he got up one morning unable to pee. His PSA at diagnosis was 38 and his cancer had spread to three lymph nodes. Once the cancer has spread, surgery isn’t an option. His brother, who was ten years younger, should’ve been tested after Jeremy’s diagnosis but wasn’t.